Tristel Regulatory News (TSTL)

9 Aug 2006 07:00

Tristel PLC09 August 2006 Tristel plc Acquisition update Tristel plc ("Tristel"), the healthcare business which uses its proprietarychlorine dioxide chemistry for infection control in hospitals, in watertreatment and the food processing industry, reports that the integration ofTristel Technologies Limited ("TTL") (previously Vernagene Limited) is makinggood progress and that the performance of the business is in line withmanagement expectations. TTL, the chlorine dioxide specialist focusing on water treatment andcontamination control in food processing, was acquired on 5th June 2006 at acost of £1,000,000, funded by cash of £800,000 and a £200,000 loan provided byone of Tristel's shareholders. Progress made with the TTL business and in Tristel's core activities in thehospital marketplace will enable Tristel to repay early the £200,000 loan frominternally generated cash flow. It is expected that the loan will be repaidduring August 2006. TTL will make a positive contribution to Tristel's results for the year ended30th June 2006 which are expected to be announced in October. For further information, please contact: Tristel plc Parkgreen Communications Ltd Paul Swinney, Chief Executive Paul McManusPaul Barnes, Finance Director Tel 020 7493 3716Tel: 01638 721 500 Mob: 07980 541 893http://www.tristel.com paul.mcmanus@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange